دورية أكاديمية

Treatment of calcium channel blocker-induced gingival overgrowth without modifying medication.

التفاصيل البيبلوغرافية
العنوان: Treatment of calcium channel blocker-induced gingival overgrowth without modifying medication.
المؤلفون: Satoru Morikawa, Mana Nasu, Yoko Miyashita, Taneaki Nakagawa
المصدر: BMJ Case Reports; 1/11/2021, p1-4, 4p
مستخلص: Gingival overgrowth is a common side effect of calcium channel blockers used in the treatment of cardiovascular diseases. While controversial, management includes discontinuing the calcium channel blocker. We report the case of a 66-year-old Japanese man with hypertension and type 2 diabetes mellitus who was diagnosed with severe periodontitis covering almost all the teeth. The patient had been on nifedipine (40 mg/day) and amlodipine (10 mg/day) medication for 5 years. With his physician’s consent, nifedipine was discontinued during his treatment for periodontitis, which consisted of oral hygiene instructions and scaling and root planing on all areas. Gingivectomy was performed on the areas of hard fibrous swelling. Nifedipine was resumed during periodontal treatment when the patient’s hypertension worsened. His periodontal scores improved when he resumed treatment. We report that significant improvement in gingival overgrowth can occur with basic periodontal treatment, surgery and sustained intensive follow-up without adjusting calcium channel blockers. [ABSTRACT FROM AUTHOR]
Copyright of BMJ Case Reports is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:1757790X
DOI:10.1136/bcr-2020-238872